The common atypical ON cases, characterized by biomarkers such as aquaporin-4 (AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies, represents distinct CNS demyelinating diseases. This evidence concerns the gene AQP4 and demyelinating disease of central nervous system.